Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:58 PM
Ignite Modification Date:
2025-12-24 @ 12:58 PM
NCT ID:
NCT04522661
Eligibility Criteria:
Inclusion Criteria:
* The patient over 18 years of age
* Patient has capacity to give informed consent
* Patient has not previously been enrolled in this study in regards to their other eye
* Diagnosis of postoperative endophthalmitis at any time-point following an ocular surgery/procedure/injection
* Patient is healthy to undergo vitrectomy surgery
* Symptomatic Visual loss attributable to POE
* Best corrected visual acuity worse than 35 ETDRS letters, including CF, HM and POL vision
Exclusion Criteria:
* Patient suffered a major thromboembolic event within the past 3 months as (defined as TIA, Stroke, or MI)
* Known adverse reaction to intravitreal antibiotics (amikacin/vancomyin/cephalosporins)
* Blood pressure greater than 200 systolic or 100 diastolic
* Any other condition that in the opinion of the investigator would preclude participation in the study (such as unstable medical status or severe disease that would make it difficult for the patient to be able to complete the study)
* The patient will use an investigational drug during the study
* History of optic atrophy in the study eye
* Corneal oedema/haze that would prevent visualisation of fundus to perform vitrectomy surgery
* Patient over the age of 95 who present with POE should immediately be placed on the pre-screening log as ineligible
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
95 Years
Study:
NCT04522661
Study Brief:
Protocol Section:
NCT04522661